Onconova Therapeutics

Onconova Therapeutics company information, Employees & Contact Information

Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer.

Company Details

Employees
20
Founded
-
Address
12 Penns Trail, Newtown,pa 18940,united States
Phone
2677593681
Email
in****@****nova.us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Newtown, PA
Looking for a particular Onconova Therapeutics employee's phone or email?

Onconova Therapeutics Questions

News

Annovis Appoints Mark Guerin as Chief Financial Officer - The Globe and Mail

Annovis Appoints Mark Guerin as Chief Financial Officer The Globe and Mail

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. - orrick.com

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. orrick.com

We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully - Yahoo Finance

We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully Yahoo Finance

Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors - citybiz

Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors citybiz

Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial - GlobeNewswire

Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial GlobeNewswire

Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD® - CNBC

Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD® CNBC

Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist

Why Onconova Therapeutics (ONTX) Stock Is Up Sharply Market Realist

Onconova closes $79.6m IPO - - Global Venturing

Onconova closes $79.6m IPO - Global Venturing

Onconova Looks to Launch Phase 1 Trial of ON 123300 in Breast Cancer - breastcancer-news.com

Onconova Looks to Launch Phase 1 Trial of ON 123300 in Breast Cancer breastcancer-news.com

Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure - Nature

Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure Nature

Onconova On The Edge After Phase III Rigosertib MDS Failure - Citeline News & Insights

Onconova On The Edge After Phase III Rigosertib MDS Failure Citeline News & Insights

GVK Bio, Onconova to develop new cancer drugs - Business Today

GVK Bio, Onconova to develop new cancer drugs Business Today

Top Onconova Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant